Studying at the University of Verona

This information is intended exclusively for students already enrolled in this course.
If you are a new student interested in enrolling, you can find information about the course of study on the course page:

Laurea magistrale a ciclo unico in Medicina e chirurgia - Enrollment from 2025/2026
Academic year:
Corsi elettivi 1° semestre From 10/9/17 To 12/21/17
years Modules TAF Teacher
Progress Test 1st year D Roberto Leone (Coordinator)
Progress Test 2nd year D Roberto Leone (Coordinator)
Supplementary research and laboratory diagnostic informations on Autoimmunity D Silvia Sartoris (Coordinator)
Role of the Medicine student in a cognitive laboratory for Nursing students D Roberto Leone (Coordinator)
Progress Test 3rd year D Roberto Leone (Coordinator)
2° 3° Access to essential medicines in developing countries D Roberto Leone (Coordinator)
Progress Test 4th year D Roberto Leone (Coordinator)
Progress Test 5th year D Roberto Leone (Coordinator)
Exercise testing and prescription for health D Federico Schena (Coordinator)
4° 5° Coagulation disorders. Diagnostic and therapeutic aspects D Francesca Pizzolo (Coordinator)
Oncologic Imaging D Mirko D'Onofrio (Coordinator)
Neurophysiological investigations for studying sleep and sleep-related disorders D Gaetano Cantalupo (Coordinator)
Progress Test 6th year D Roberto Leone (Coordinator)
5° 6° Topics of hepatology from medical and surgical point of view D Franco Capra (Coordinator)
5° 6° Research methodology basis and critical reading of a scientific article D Giuseppe Borzellino (Coordinator)
5° 6° Basic course ECG and interactive interpretation D Vincenzo Marafioti (Coordinator)
5° 6° Nutritional Epigenomics: a bridge between DNA and disease D Simonetta Friso (Coordinator)
5° 6° Surgery of the liver: from the preoperative optimization of the liver to the postoperative care D Calogero Iacono (Coordinator)
5° 6° Traditional and endovascular surgery of abdominal aortic aneurisms D Alberto Scuro (Coordinator)
5° 6° Multiple Sclerosis and demyelinating diseases of the central nervous system: from diagnosis to therapy D Massimiliano Calabrese (Coordinator)
5° 6° Uncommon pancreatic neoplasms D Roberto Salvia (Coordinator)
5° 6° Extracorporeal life support D Alessio Rungatscher (Coordinator)
5° 6° Minimally invasive (laparoscopic and robot-assisted) surgery in abdominal diseases (videos and dry-lab) D Corrado Pedrazzani (Coordinator)
5° 6° Technologies in Surgery D Roberto Salvia (Coordinator)
5° 6° Sport's Traumatology D Eugenio Vecchini (Coordinator)
4° 5° 6° Clinical cases in endocrinology and metabolism D Enzo Bonora (Coordinator)
4° 5° 6° Abdominal wall surgery D Antonino Zago (Coordinator)
4° 5° 6° Physiology and pathophysiology of micturition D Maria Angela Cerruto (Coordinator)
4° 5° 6° Physiopathology of low back pain and degenerative spondiloarthritis D Bruno Magnan (Coordinator)
4° 5° 6° Autism Spectrum Disorders: clinic, etiology, research D Leonardo Zoccante (Coordinator)
4° 5° 6° Musculoskeletal Assessment D Luca Idolazzi (Coordinator)
4° 5° 6° Pigmented cutaneous lesions and melanoma: clinical evaluation and differential diagnosis D Paolo Rosina (Coordinator)
4° 5° 6° Child development: a neurodevelopmental approach D Alessandro Simonati (Coordinator)
4° 5° 6° Technologies applied to type 1 diabetes mellitus: towards artificial pancreas D Maddalena Trombetta (Coordinator)
4° 5° 6° Stem cell transplantation: biological and clinical issues D Mauro Krampera (Coordinator)
4° 5° 6° Tubercolosis: epidemiology, pathogenesis, clinical features, therapy and surveillaince D Michela Conti (Coordinator)
3° 4° 5° 6° Traditional and laser treatment of chronic venous insufficiency D Alberto Scuro (Coordinator)
3° 4° 5° 6° Immunophenotyping in normal hematopoiesis and in hematological diseases D Mauro Krampera (Coordinator)
3° 4° 5° 6° Interpretation of laboratory data: from theory to practice D Gian Luca Salvagno (Coordinator)
2° 3° 4° 5° 6° Medical and social history of drugs D Fabio Lugoboni (Coordinator)
1° 2° 3° 4° 5° 6° Alcoholism D Marco Faccini (Coordinator)
1° 2° 3° 4° 5° 6° Heroin and cocaine. History, epidemiology, new scenarios, clinical approach, complications. Serts. D Marco Faccini (Coordinator)
1° 2° 3° 4° 5° 6° School of Medicine and Surgery Seminars, 2017-2018 D Roberto Leone (Coordinator)
Corsi elettivi 2° semestre From 2/19/18 To 5/25/18
years Modules TAF Teacher
1° 2° Bioinformatics D Maria Romanelli (Coordinator)
2° 3° Molecular biology of emerging viruses D Donato Zipeto (Coordinator)
2° 3° Human retroviruses: HIV and AIDS D Donato Zipeto (Coordinator)
1° 2° 3° Psychological aspects of addiction D Fabio Lugoboni (Coordinator)
1° 2° 3° Short history of pharmacology D Roberto Leone (Coordinator)
1° 2° 3° Motivational interviewing D Fabio Lugoboni (Coordinator)
1° 2° 3° Dependence on legal drugs (benzodiazepines and pain killers) D Fabio Lugoboni (Coordinator)
1° 2° 3° Doping and doping control D Aldo Eliano Polettini (Coordinator)
1° 2° 3° Gambling D Fabio Lugoboni (Coordinator)
1° 2° 3° Tabagism D Fabio Lugoboni (Coordinator)
1° 2° 3° Intervento sanitario breve D Fabio Lugoboni (Coordinator)
1° 2° 3° role and management of therapeutic groups in medicine D Fabio Lugoboni (Coordinator)
1° 2° 3° History of surgery D Giovanni Paolo Pollini (Coordinator)
Clinical electrocardiography D Daniele Prati (Coordinator)
Surgical anatomy of head and neck D Daniele Marchioni (Coordinator)
Clinical approach to cancer patient D Giampaolo Tortora (Coordinator)
Clinical ultrasound D Mirko D'Onofrio (Coordinator)
4° 5° Off-label use of medicines in clinical practice D Laura Cuzzolin (Coordinator)
4° 5° Pancreatic neoplasms: clinic-pathologic features D Giuseppe Zamboni (Coordinator)
4° 5° Nodule of the thyroid: clinicopathologic correlations D Guido Martignoni (Coordinator)
5° 6° Advanced life support D Enrico Polati (Coordinator)
5° 6° Surgery of pancreas and peryampullary area D Calogero Iacono (Coordinator)
5° 6° Neonatal surgery D Francesco Saverio Camoglio (Coordinator)
5° 6° Surgical oncology of the gastrointestinal tract D Corrado Pedrazzani (Coordinator)
5° 6° Clinical, diagnostic and therapeutic aspects of retroperitoneal tumors and GIST D Calogero Iacono (Coordinator)
5° 6° Diagnosis and treatment of benign and malignant diseases of biliary tree D Andrea Ruzzenente (Coordinator)
5° 6° Emergencies in the extra-hospital environment D Enrico Polati (Coordinator)
5° 6° Management of pain in reumathologic diseases D Davide Gatti (Coordinator)
5° 6° Pancreatic dilemma between inflammation and neoplasia D Antonio Amodio (Coordinator)
5° 6° Imaging in reumathology D Maurizio Rossini (Coordinator)
5° 6° Introduction to Robotic Surgery D Paolo Fiorini (Coordinator)
5° 6° Literature search using PubMed D Roberto Leone (Coordinator)
5° 6° Infection in ICU D Anna Maria Azzini (Coordinator)
5° 6° Parkinson's Disease and Movement Disorders D Stefano Tamburin (Coordinator)
5° 6° Experimental microsurgery D Alessio Rungatscher (Coordinator)
5° 6° Clinical senology D Giovanni Paolo Pollini (Coordinator)
5° 6° Intra-articular onjection in Rheumatology D Elena Fracassi (Coordinator)
5° 6° Clinical toxicology in the Emergency Department and CBRN events D Giorgio Ricci (Coordinator)
5° 6° Ablative treatments in hepatobiliopancreatic surgery D Salvatore Paiella (Coordinator)
4° 5° 6° Colordroppler ultrasound of carotid arteries, lower limbs and abdominal vessels D Sergio De Marchi (Coordinator)
4° 5° 6° Diagnosis in pediatric allergy D Giorgio Piacentini (Coordinator)
4° 5° 6° Gynecological endocrinology D Paolo Moghetti (Coordinator)
4° 5° 6° Diagnosis of Disease based on the laboratory analysis: from theory to practice D Gian Luca Salvagno (Coordinator)
4° 5° 6° Tumor immunology and immunomodulation D Stefano Ugel (Coordinator)
4° 5° 6° Intraoperative neurophysiology: a functional approach to modern neurosurgery D Francesco Sala (Coordinator)
4° 5° 6° Therapy with biologic agents in rheumatic diseases D Ombretta Viapiana (Coordinator)
4° 5° 6° Tropical Medicine D Michela Conti (Coordinator)
4° 5° 6° Psysiopathology of the foot in childhood and in adults D Bruno Magnan (Coordinator)
4° 5° 6° Physical Medicine and Rehabilitation D Nicola Smania (Coordinator)
4° 5° 6° Humanitarian Medicine and Surgery D Elda Baggio (Coordinator)
4° 5° 6° Bioethic issues in Human Genetics D Alberto Turco (Coordinator)
4° 5° 6° Non-pharmacological treatment of pain in surgery: music therapy D Giovanni Paolo Pollini (Coordinator)
4° 5° 6° Multimodal treatment of pancreatic neoplasms D Giuseppe Malleo (Coordinator)
3° 4° 5° 6° Practical issues in genetic counseling D Alberto Turco (Coordinator)
3° 4° 5° 6° Women and medicine D Elda Baggio (Coordinator)
2° 3° 4° 5° 6° Training to medical humanities D Roberto Leone (Coordinator)
1° 2° 3° 4° 5° 6° Medical Deontology D Federica Bortolotti (Coordinator)
1° 2° 3° 4° 5° 6° Medical and antropological emergencies in third world countries D Mariarita Bertoldi (Coordinator)
1° 2° 3° 4° 5° 6° Stress reduction D Fabio Lugoboni (Coordinator)

Teaching code

4S01147

Credits

9

Language

Italian

The teaching is organized as follows:

FARMACOLOGIA GENERALE E SPECIALE

Credits

8

Period

Lezioni 1° semestre 2°- 6° anno, Lezioni 2° semestre 1°- 5° anno

Location

VERONA

FARMACOVIGILANZA

Credits

1

Period

Lezioni 2° semestre 1°- 5° anno

Location

VERONA

Academic staff

Roberto Leone

Learning outcomes

------------------------ MM: FARMACOLOGIA GENERALE E SPECIALE ------------------------ General aims Aim of the course is education in pharmacology, i.e. reach a firm understanding that a drug is a tool intended to modify the wellbeing of the patients by interacting with molecular components of the cells and tissues. This interaction leads to modulation of physiological and pathological processes responsible of health and disease. The student will learn to use his/her knowledge in basic biomedical sciences with the goal of understanding the mechanism of action of a compound and the generation of therapeutic and toxic effects and adverse reactions. The student will appreciate the links connecting the effects (beneficial and adverse) with the plasmatic levels of a drug. Accordingly, he will learn the basic principles guiding the generation of plasma levels and their temporal changes and the effects of individual properties (genetic, metabolic, presence of diseases) on these dinamic changes. During the course teachers and students will explore the proprties (mechanisms of action, therapeutic, adverse rections, pharmacokinetic) of classes of drugs active on the Nervous System (Central, Periferal and Autonomic), on the Cardiovascular, the gastrointestinal and the endocrine systems; the pharmacological modulation of inflammatory, immune, infective and oncological processes will also be addressed. Specific aims At the end of the course the student will: know the rationale of therapies in order to select and use drugs on the basis of the pathology, the health of the patient, the scientific evidences of effectivness. He/she will also be able to monitor the efficacy of the therapy, the generation of positive symptoms and of adverse reactions. know the classification of drugs also in the context of the National Health System, how to prescribe a drug and the use of appropriate data bases also in the context of the Italian National Health System. kown the preclinical and clinical development of drugs, the organization of clinical studies and will be able to critically read the results of clinical studies and the use of their results in the daily practice understand the basic pharmacodynamic principles governing drug-receptor interaction and the generation of the effects with focus on signal transduction generated by activation/inhibition of drug receptors such as enzymes, ion channels, receptors for endogenous mediators with special interest to ligand activated ion-channel, G protein coupled receptors and intracellular receptors. understand the basic principles of pharmacokinetics know how to use pharmacokinetic criteria and data to establish individualized therapeutic regimens know for each class of drug the mechanism(s) of action and the symptoms generated in order to monitor efficacy and possible toxicity of the therapy; know the major differences between drugs belonging to a same class of drugs and the criteria for the selection for individualized therapy know the pharmacological properties, as described above, of the following classes of drugs: • active on the autonomic, peripheral and central nervous system • used in pulmunary diseases • active on the cardivascular system • active on the metabolic/endocrine systems • used for the control of infectious diseases • use to control inflammatory conditions • active on the immunesystem • used in oncology ------------------------ MM: FARMACOVIGILANZA ------------------------ At the end of the Pharmacovigilance module, the student must have achieved the following objectives: > Understand the etiopathogenetic mechanisms of adverse drug reactions > Understand the international classification of adverse drug reactions > Know the main epidemiological data on adverse drug reactions > Know the most important methods for the study of drug safety > Know to fill out a report of adverse drug reaction

Program

------------------------
MM: FARMACOLOGIA GENERALE E SPECIALE
------------------------
Detailed programme of the course Drug and placebo definition; historic and modern views of drugs Bioequivalent and biosimilar drugs Drug classification in Pharmacology and by the National Health System Drug development, clinical trials and postmarketing monitoring Pharmacodynamics: drug-receptor interaction, signal transduction and effect generation Pharmacokinetics: general principles, absorption, distribution, elimination and drug metabolism Pharmacogenetics and drug therapy individualization Pgharnmacogenetics and biotransformation of drugs Drugs acting on the autonomic system Drugs acting on the respiratory system Drugs active on the gastrointestinal system Drugs affecting platelet aggregation, the coagulation system including fibrinolytic agents Drugs for the control of dislipidemic states Drugs acting on the Periferal and the central Nervous System Drugs interacting with autacoids Pharmacology of the inflammation Drugs for the cardiovascular system and the therapies of cardiovascular disorders Ipoglicemic drugs including insulin Drugs active on the immune system Drugs used for the control of infections Antineoplastic therapies
------------------------
MM: FARMACOVIGILANZA
------------------------
WHO and EMA definitions of Adverse Drug Reaction (ADR) International Classification of ADRs: Types A, B, C, D, E, F Serious and non-serious adverse reactions: distinctive criteria; specific and non-specific ADRs Epidemiology of ADRs; data on morbidity and mortality Pathogenetic mechanisms of ADRs: dose-dependent and -independent; allergic reactions; pharmacogenetic reactions; teratogenicity; carcinogenesis Drugs in pregnancy and breastfeeding Pediatric adverse drug reactions Adverse drug reactions in the elderly patients Drug-drug interactions as cause of ADR Economic impact of ADRs Pharmacovigilance definition and history The reasons and objectives of Pharmacovigilance Main methodologies for the study of drug tolerability The Italian ADRs reporting system Italian and European pharmacovigilance legislation The Italian reporting card: criteria for compilation The Vigifarmaco Platform (on-line reporting) ADR reporting by citizens Web Searching and Big-Data

Bibliography

Reference texts
Author Title Publishing house Year ISBN Notes
Bertram G. Katzung Basic and Clinical Pharmacology (Edizione 13) McGraw-Hill Education 2015 978-0-07-182505-3
F. Rossi, V. Cuomo, C. Riccardi Farmacologia (Edizione 3) Minerva Medica 2017 978-88-7711-881-3
B. G. Katzung & A. J. Trevor Farmacologia Generale e Clinica (Edizione 10) Piccin-Nuova Libraria 2017 978-88-299-2847-7
Goodman & Gilman The pharmacological basis of therapeutics (Edizione 13) McGraw-Hill Education 2017 9780071624428
Clementi Fumagalli Farmacologia Generale e Molecolare (Edizione 5) Edra 2018 978-88-214-4436-4
Goodman & Gilman Le basi farmcologiche della terapia (Edizione 12) Zanichelli 2012 9788808261304
Stephns, Talbot, Routledge Detection of New Adverse Drug Reactions 1999
Caputi, De Ponti, Pagliaro Reazioni avverse a farmaci Cortina Editore 2009 978-88-6030-278-6

Examination Methods

Oral exam with question of general principles as well as on specific drugs and/or classes of drugs in a therapeutic context

Students with disabilities or specific learning disorders (SLD), who intend to request the adaptation of the exam, must follow the instructions given HERE